Security key
75955J402
RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (RLMD)
CUSIP: 75955J402
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 7,739,580
- Total 13F value
- $15,541,689
- Share change
- +2,426,423
- SEC-reported price per share
- $2.01
- Number of holders
- 43
- Value change
- +$5,248,275
- Number of buys
- 13
- Number of sells
- 19
- Shares outstanding
- 103,817,091
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
43
Top holders
10
RLMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
RELMADA THERAPEUTICS, INC. SEC filings
RELMADA THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75955J402
Recent filing periods:
Ownership snapshot
Top reported holders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 4.8%
13D/G row: Ikarian Capital, LLC
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC leads the comparable SEC ownership view at 4.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Ikarian Capital, LLC
4.8%
DRIEHAUS CAPITAL MANAGEMENT LLC
0.71%
ACADIAN ASSET MANAGEMENT LLC
0.6%
BlackRock, Inc.
0.49%
AdvisorShares Investments LLC
0.38%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13D/G
13F
Company
|
4.8%
|
$7,122,152
3,543,359 shares
|
$0 | 30 Sep 2025 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
0.71%
|
$444,226
740,006 shares
|
— | 30 Jun 2025 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
0.6%
|
$371,000
619,479 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
0.49%
|
$304,952
508,000 shares
|
— | 30 Jun 2025 |
| AdvisorShares Investments LLC |
13F
Company
|
0.38%
|
$238,027
396,514 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.35%
|
$218,446
364,077 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
7,739,580
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
48
Q3 2025 holders
43
Holder diff
-5
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend